Biomarkers: when to test, what to test and what are the consequences?

MEET THE EXPERTS ALL PROGRAMMES DEVELOPED COLLABORATIONS CONTACT

Biomarkers: when to test, what to test and what are the consequences?

Dr. Thomas Winder

Dr. Thomas Winder, Dr. Andrea Sartore-Bianchi and Dr. Yu Sunakawa discuss the Clinical Question: Biomarkers: when to test, what to test and what are the consequences?

Dr. Thomas Winder

Medical Oncologist

University Teaching Hospital Feldkirch

Austria

time | open 5 min | 2016

download resources

Download the slides

I agree that this educational programme:

GI CONNECT is an initiative of COR2ED, supported by an Independent Educational Grant from Bayer.

Other programmes of interest

Update from ASCO GI

Jan 2023

Accreditation: EACCME

PARP inhibitors in prostate cancer and the rationale behind combi...

Jan 2023

Optimising treatment sequencing for mCRC, third line and beyond

Jan 2023

Highlights from CTOS 2022

Jan 2023

Update From ASH 2022

Dec 2022

Targeted and Immunotherapies for Advanced Renal Cell Carcinoma

Dec 2022

Update From San Antonio Breast Cancer Symposium 2022

Dec 2022

Publication Snapshot: Regorafenib for the Treatment of Sarcoma

Dec 2022

Insights into real-world data in advanced HCC

Dec 2022

Early Treatment Intensification for mCSPC: Optimising Patient Sel...

Dec 2022

Current perspectives on TRK fusion-positive thyroid cancers

Dec 2022

Early-onset Colorectal Cancer

Nov 2022

Other programmes developed by Dr. Thomas Winder

Dr. Thomas Winder

Medical Oncologist

University Teaching Hospital Feldkirch

Austria

GI CONNECT Update from ESMO 2022

Sep 2022

Update From ESMO 2022 Presidential Sessions

Sep 2022

Review paper on circulating tumor DNA in colorectal cancer

2017

GI CONNECT Update from ASCO GI 2015: pancreas, small bowel and he...

2015

GI CONNECT Update from ASCO GI 2016: cancers of the liver, small ...

2016

GI CONNECT update from ASCO GI 2017: cancers of the upper GI trac...

2017

GI CONNECT update from ASCO and WCGIC 2017: cancers of the liver,...

2017

GI CONNECT update from ASCO GI 2018: cancers of the lower GI trac...

2018

What are the pros and cons of adjuvant treatment in stage II colo...

2018

Cookie	Duration	Description
cookielawinfo-checkbox-analytics	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional	11 months	The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy	11 months	The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.